文献速递流行病学与生物统计组学、生物样本库与精准医学基础与转化研究

跨生物银行67.6万人分析揭示复杂性状多基因风险评分与人类寿命的关联

Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan.
PubMed 文献 · Nat Med · 2020-03-23

该研究联合日本生物银行、英国生物银行和FinnGen三个生物银行共675,898人,分析复杂性状多基因风险评分(PRS)与寿命的关联。高收缩压PRS跨种族与较短寿命及父母寿命相关,肥胖PRS对日本和欧洲个体寿命影响不同,孟德尔随机化支持血压和肥胖对寿命的因果效应。

要点

  • 高收缩压PRS与较短寿命跨种族相关(HR=1.03)。
  • 肥胖PRS对日本和欧洲个体寿命影响存在异质性。
  • 孟德尔随机化支持血压和肥胖对寿命的因果效应。

核心结论

  • 多基因风险评分可帮助识别影响人类寿命的可干预驱动生物标志物。
  • 血压和肥胖对寿命的因果效应得到孟德尔随机化支持。

研究设计与样本

  • 联合三个生物银行(日本生物银行n=179,066、英国生物银行n=361,194、FinnGen n=135,638)共675,898人的跨生物银行分析。
  • 采用多基因风险评分(PRS)分析复杂性状遗传易感性与寿命的关联,并辅以孟德尔随机化。

主要发现

  • 高收缩压PRS跨种族与较短寿命相关(HR=1.03[1.02-1.04],Pmeta=3.9×10-13)。
  • 高收缩压PRS与较短父母寿命相关(HR=1.06[1.06-1.07],P=2.0×10-86)。
  • 肥胖PRS对日本和欧洲个体寿命影响不同(BMI异质性P=9.5×10-8)。

临床怎么用

  • 可利用PRS优先关注血压和肥胖等可干预风险因素以改善人群健康。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

While polygenic risk scores (PRSs) are poised to be translated into clinical practice through prediction of inborn health risks1, a strategy to utilize genetics to prioritize modifiable risk factors driving heath outcome is warranted2. To this end, we investigated the association of the genetic susceptibility to complex traits with human lifespan in collaboration with three worldwide biobanks (ntotal = 675,898; BioBank Japan (n = 179,066), UK Biobank (n = 361,194) and FinnGen (n = 135,638)). In contrast to observational studies, in which discerning the cause-and-effect can be difficult, PRSs could help to identify the driver biomarkers affecting human lifespan. A high systolic blood pressure PRS was trans-ethnically associated with a shorter lifespan (hazard ratio = 1.03[1.02-1.04], Pmeta = 3.9 × 10-13) and parental lifespan (hazard ratio = 1.06[1.06-1.07], P = 2.0 × 10-86). The obesity PRS showed distinct effects on lifespan in Japanese and European individuals (Pheterogeneity = 9.5 × 10-8 for BMI). The causal effect of blood pressure and obesity on lifespan was further supported by Mendelian randomization studies. Beyond genotype-phenotype associations, our trans-biobank study offers a new value of PRSs in prioritization of risk factors that could be potential targets of medical treatment to improve population health.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Sakaue S, Kanai M, Karjalainen J, et al. Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan. Nat Med. 2020. PMID: 32251405. doi:10.1038/s41591-020-0785-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。